久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Artios Pharma raises £65m to develop DDR therapies pharmatimes
    August 13, 2018
    Cambridge-based biotech Artios Pharma has raised £65 million in series B financing from investors including Pfizer and Novartis, to further its development DNA Damage Response (DDR) therapies for cancer.
PharmaSources Customer Service